drugset / Trial / NCT01710631
Twelve Month Study of the Safety of Eszopiclone in Adult Subjects With Insomnia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A six-month study to determine the safety and efficacy with an additional open-label extension to determine the long-term safety of eszopiclone in the treatment of adult subjects with primary insomnia.
Timeline
- Start
- 2001-02
- Primary completion
- 2002-08
- Completion
- 2002-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eszopiclone | Small molecule | 3 mg | — |